Last reviewed · How we verify
Dasatinib, Paclitaxel, and Carboplatin
Dasatinib, Paclitaxel, and Carboplatin is a Small molecule drug developed by AA Secord. It is currently in Phase 1 development. Also known as: Dasatinib, Paclitaxel, Carboplatin, Taxol.
At a glance
| Generic name | Dasatinib, Paclitaxel, and Carboplatin |
|---|---|
| Also known as | Dasatinib, Paclitaxel, Carboplatin, Taxol, Paraplatin |
| Sponsor | AA Secord |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dasatinib, Paclitaxel, and Carboplatin CI brief — competitive landscape report
- Dasatinib, Paclitaxel, and Carboplatin updates RSS · CI watch RSS
- AA Secord portfolio CI
Frequently asked questions about Dasatinib, Paclitaxel, and Carboplatin
What is Dasatinib, Paclitaxel, and Carboplatin?
Dasatinib, Paclitaxel, and Carboplatin is a Small molecule drug developed by AA Secord.
Who makes Dasatinib, Paclitaxel, and Carboplatin?
Dasatinib, Paclitaxel, and Carboplatin is developed by AA Secord (see full AA Secord pipeline at /company/aa-secord).
Is Dasatinib, Paclitaxel, and Carboplatin also known as anything else?
Dasatinib, Paclitaxel, and Carboplatin is also known as Dasatinib, Paclitaxel, Carboplatin, Taxol, Paraplatin.
What development phase is Dasatinib, Paclitaxel, and Carboplatin in?
Dasatinib, Paclitaxel, and Carboplatin is in Phase 1.
Related
- Manufacturer: AA Secord — full pipeline
- Also known as: Dasatinib, Paclitaxel, Carboplatin, Taxol, Paraplatin
- Compare: Dasatinib, Paclitaxel, and Carboplatin vs similar drugs
- Pricing: Dasatinib, Paclitaxel, and Carboplatin cost, discount & access